| The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors U Hengst, H Albrecht, D Hess, D Monard Journal of Biological Chemistry 276 (1), 535-540, 2001 | 220 | 2001 |
| Bcl‐2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF‐κB by TNF H Albrecht, J Tschopp, CV Jongeneel FEBS letters 351 (1), 45-48, 1994 | 123 | 1994 |
| Cercarial elastase is encoded by a functionally conserved gene family across multiple species of schistosomes JP Salter, Y Choe, H Albrecht, C Franklin, KC Lim, CS Craik, ... Journal of Biological Chemistry 277 (27), 24618-24624, 2002 | 121 | 2002 |
| Discovery of 5‐(2‐(Phenylamino)pyrimidin‐4‐yl)thiazol‐2(3H)‐one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation S Diab, T Teo, M Kumarasiri, P Li, M Yu, F Lam, SKC Basnet, MJ Sykes, ... ChemMedChem 9 (5), 962-972, 2014 | 84 | 2014 |
| CDK9: a comprehensive review of its biology, and its role as a potential target for anti-cancer agents AT Anshabo, R Milne, S Wang, H Albrecht Frontiers in oncology 11, 678559, 2021 | 79 | 2021 |
| Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor γ activity: a combined virtual screening and biological assay approach M Scarsi, M Podvinec, A Roth, H Hug, S Kersten, H Albrecht, T Schwede, ... Molecular pharmacology 71 (2), 398-406, 2007 | 78 | 2007 |
| Targeting CDK9: a promising therapeutic opportunity in prostate cancer MH Rahaman, M Kumarasiri, LB Mekonnen, M Yu, S Diab, H Albrecht, ... Endocrine-related cancer 23 (12), T211-T226, 2016 | 70 | 2016 |
| Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug … S Tadesse, M Yu, LB Mekonnen, F Lam, S Islam, K Tomusange, ... Journal of Medicinal Chemistry 60 (5), 1892-1915, 2017 | 65 | 2017 |
| Regulation of brain proteolytic activity is necessary for the in vivo function of NMDA receptors M Kvajo, H Albrecht, M Meins, U Hengst, E Troncoso, S Lefort, JZ Kiss, ... Journal of Neuroscience 24 (43), 9734-9743, 2004 | 60 | 2004 |
| Use of FLIPR membrane potential dyes for validation of high-throughput screening with the FLIPR and µARCS technologies: identification of ion channel modulators acting on the … C Joesch, E Guevarra, SP Parel, A Bergner, P Zbinden, D Konrad, ... Journal of biomolecular screening 13 (3), 218-228, 2008 | 51 | 2008 |
| trans activation of the tumor necrosis factor alpha promoter by the human T-cell leukemia virus type I Tax1 protein H Albrecht, AN Shakhov, CV Jongeneel Journal of virology 66 (10), 6191-6193, 1992 | 48 | 1992 |
| Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles W Zhang, Y Song, P Eldi, X Guo, JD Hayball, S Garg, H Albrecht International Journal of Nanomedicine, 293-305, 2018 | 43 | 2018 |
| CDK5 in oncology: recent advances and future prospects JL Lenjisa, S Tadesse, NZ Khair, M Kumarasiri, M Yu, H Albrecht, R Milne, ... Future medicinal chemistry 9 (16), 1939-1962, 2017 | 41 | 2017 |
| Pharmacologic inhibition of MNKs in acute myeloid leukemia T Teo, F Lam, M Yu, Y Yang, SKC Basnet, H Albrecht, MJ Sykes, S Wang Molecular pharmacology 88 (2), 380-389, 2015 | 40 | 2015 |
| Discovery of 4-(dihydropyridinon-3-yl) amino-5-methylthieno [2, 3-d] pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure–activity relationship analysis and … M Yu, P Li, SKC Basnet, M Kumarasiri, S Diab, T Teo, H Albrecht, S Wang European journal of medicinal chemistry 95, 116-126, 2015 | 40 | 2015 |
| Nuclear migration of NF-kappa B correlates with TNF-alpha mRNA accumulation. H Albrecht, LB Schook, CV Jongeneel Journal of inflammation 45 (1), 64-71, 1995 | 40 | 1995 |
| Single amino acid substitutions in the B870 α and β light‐harvesting polypeptides of Rhodobacter capsulatus Structural and spectral effects M Babst, H Albrecht, I Wegmann, R Brunisholz, H Zuber European journal of biochemistry 202 (2), 277-284, 1991 | 35 | 1991 |
| An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis T Teo, Y Yang, M Yu, SKC Basnet, T Gillam, J Hou, RM Schmid, ... European journal of medicinal chemistry 103, 539-550, 2015 | 34 | 2015 |
| Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: Potential for active targeting with engineered anti-cancer nanomedicines E Kübler, H Albrecht Oncotarget 9 (38), 24882, 2018 | 31 | 2018 |
| Targeting prostate cancer cells with genetically engineered polypeptide-based micelles displaying gastrin-releasing peptide W Zhang, S Garg, P Eldi, FH Zhou, IRD Johnson, DA Brooks, F Lam, ... International Journal of Pharmaceutics 513 (1-2), 270-279, 2016 | 29 | 2016 |
